This is consistent with studies showing that components of metabolic syndrome—such as obesity, hypertension, and hyperglycemia—promote chronic inflammation through adipocytokine secretion and transforming growth factor-beta (TGF-β) pathway activation (40, 41). This evidence concerns the gene TGFB1 and hypertensive disorder.